BrainStorm Cell Therapeutics
BCLI
#10078
Rank
A$17.4 M
Marketcap
$3.05
Share price
-5.03%
Change (1 day)
-55.37%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -A$14.84 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$39.2 Million, an increase over its 2021 earnings that were of -A$39.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$14.84 Million
2022 -A$39.2 Million-0.74%
2021 -A$39.49 Million-23.12%
2020 -A$51.36 Million36.8%
2019 -A$37.54 Million66.71%
2018 -A$22.52 Million181.66%
2017 -A$8 Million-0.6%
2016 -A$8.05 Million-41.31%
2015 -A$13.71 Million-8.22%
2014 -A$14.93 Million89.74%
2013 -A$7.87 Million42.27%
2012 -A$5.54 Million-12.45%
2011 -A$6.32 Million63.04%
2010 -A$3.88 Million35.52%
2009 -A$2.86 Million-48.99%
2008 -A$5.61 Million-44.39%
2007 -A$10.08 Million
2005 -A$5.22 Million-91.44%
2004 -A$61 Million94007.62%
2003 -A$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.28 B-1,882.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.94 Billion 5,736.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.28 Billion 7,905.02%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.07 B-19,400.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.16 Billion 840.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.42 Billion 2,486.97%๐Ÿ‡บ๐Ÿ‡ธ USA